The risk associated with hyperoncotic colloids in patients with shock

ObjectiveCrystalloids, artificial and natural colloids have been opposed as representing different strategies for shock resuscitation, but it may be relevant to distinguish fluids based on their oncotic characteristics. This study assessed the risk of renal adverse events in patients with shock resuscitated using hypooncotic colloids, artificial hyperoncotic colloids, hyperoncotic albumin or crystalloids, according to physician’s choice.Participants and settingInternational prospective cohort study including 1,013 ICU patients needing fluid resuscitation for shock. Patients suffering from cirrhosis or receiving plasma were excluded.Measurements and resultsInfluence of different types of colloids and crystalloids on the occurrence of renal events (twofold increase in creatinine or need for dialysis) and mortality was assessed using multivariate analyses and propensity score. Statistical adjustment was based on severity at the time of resuscitation, risks factor for renal failure, and on variables influencing physicians’ preferences regarding fluids. A renal event occurred in 17% of patients. After adjustment on potential confounding factors and on propensity score for the use of hyperoncotic colloids, the use of artificial hyperoncotic colloids [OR: 2.48 (1.24–4.97)] and hyperoncotic albumin [OR: 5.99 (2.75–13.08)] was significantly associated with occurrence of renal event. Overall ICU mortality was 27.1%. The use of hyperoncotic albumin was associated with an increased risk of ICU death [OR: 2.79 (1.42–5.47)].ConclusionsThis study suggests that harmful effects on renal function and outcome of hyperoncotic colloids may exist. Although an improper usage of these compounds and confounding factors cannot be ruled out, their use should be regarded with caution, especially because suitable alternatives exist.

[1]  D. Schmartz,et al.  3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[2]  L. Brochard,et al.  Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. , 2003, JAMA.

[3]  J. Vincent.  Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. , 2004, American journal of respiratory and critical care medicine.

[4]  J. Boldt,et al.  The influence of different intravascular volume replacement regimens on renal function in the elderly. , 1999, Anesthesia and analgesia.

[5]  M. Navasa,et al.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. , 1999, The New England journal of medicine.

[6]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.

[7]  M. Haupt,et al.  Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. , 1983, Critical care medicine.

[8]  D. Spahn,et al.  Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury , 2003, Anesthesia and analgesia.

[9]  J. Boldt,et al.  Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: A comparison with human albumin* , 2007, Critical care medicine.

[10]  M. Abel,et al.  Renal failure associated with unrecognized hyperoncotic states after pediatric heart surgery , 1996, Intensive Care Medicine.

[11]  S Lemeshow,et al.  The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. , 1996, JAMA.

[12]  I. C. Tudor,et al.  The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.

[13]  D. Hunter,et al.  First, gather the data. , 2006, The New England journal of medicine.

[14]  L. Brochard,et al.  Preferred plasma volume expanders for critically ill patients: results of an international survey , 2004, Intensive Care Medicine.

[15]  D. Rubin,et al.  Reducing Bias in Observational Studies Using Subclassification on the Propensity Score , 1984 .

[16]  S. Liljedahl,et al.  Plasma volume changes after infusion of various plasma expanders. , 1976, Resuscitation.

[17]  Corinne Alberti,et al.  The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. , 1996, JAMA.

[18]  G. Hempelmann,et al.  Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment. , 2001, Journal of clinical anesthesia.

[19]  L. Brochard,et al.  Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study , 2001, The Lancet.

[20]  P. Gosling,et al.  Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery , 2007, The British journal of surgery.

[21]  Rolf Rossaint,et al.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.

[22]  C. Mélot,et al.  Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. , 2003, British journal of anaesthesia.

[23]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[24]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[25]  J. Vincent,et al.  Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study* , 2006, Critical care medicine.

[26]  T. Brenner,et al.  RETRACTED ARTICLE: Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin , 2003, Intensive Care Medicine.

[27]  E. Burdett,et al.  Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers , 2004, Anaesthesia.

[28]  T. Stewart,et al.  Influences on physicians' choices of intravenous colloids , 2002, Intensive Care Medicine.

[29]  R. Bellomo,et al.  Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group , 2004, Critical care.

[30]  J. Avorn,et al.  Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. , 2003, Kidney international.

[31]  D. Gore,et al.  Colloid infusions reduce glomerular filtration in resuscitated burn victims. , 1996, The Journal of trauma.

[32]  W. Burnett,et al.  AIDS-related Kaposi's sarcoma in New York City in 1977. , 1988, The New England journal of medicine.

[33]  P. Coriat,et al.  Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients , 1996, The Lancet.

[34]  J. Concato,et al.  A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.

[35]  Stanley Lemeshow,et al.  The Logistic Organ Dysfunction System , 1997 .

[36]  P. Schüpbach,et al.  Perfusate Oncotic Pressure During Cardiopulmonary Bypass , 1978 .

[37]  J. Boldt,et al.  Plasma substitutes. , 2005, Minerva anestesiologica.

[38]  G. Bernard,et al.  A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury* , 2005, Critical care medicine.

[39]  E. J. Mees,et al.  Renal haemodynamics and sodium handling after hyperoncotic albumin infusion in sodium‐restricted normal man , 1987, European journal of clinical investigation.

[40]  M. Ragaller,et al.  Volume replacement in critically ill patients with acute renal failure. , 2001, Journal of the American Society of Nephrology : JASN.

[41]  Ernest E Moore,et al.  The next generation in shock resuscitation , 2004, The Lancet.

[42]  G. Jackson,et al.  Gram-Negative Bacteremia: I. Etiology and Ecology , 1962 .

[43]  P. Schüpbach,et al.  Perfusate oncotic pressure during cardiopulmonary bypass. Optimum level as determined by metabolic acidosis, tissue edema, and renal function. , 1978, Vox sanguinis.

[44]  W. Druml.  Acute renal failure is not a “cute” renal failure! , 2004, Intensive Care Medicine.

[45]  J. Rudolf.  Hydroxyethyl Starch for Hypervolemic Hemodilution in Patients with Acute Ischemic Stroke: A Randomized, Placebo-Controlled Phase II Safety Study , 2002, Cerebrovascular Diseases.

[46]  H. Wunsch,et al.  Methods to adjust for bias and confounding in critical care health services research involving observational data. , 2006, Journal of critical care.

[47]  J. Vincent,et al.  Effects of hydroxyethyl starch administration on renal function in critically ill patients. , 2005, British journal of anaesthesia.

[48]  M. Moran,et al.  Acute renal failure associated with elevated plasma oncotic pressure. , 1987, The New England journal of medicine.

[49]  J. E. Carceller.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[50]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[51]  C. Hermans,et al.  Priming solutions for cardiopulmonary bypass: comparison of three colloids. , 1991, Journal of cardiothoracic and vascular anesthesia.

[52]  P. Alderson,et al.  Colloids versus crystalloids for fluid resuscitation in critically ill patients. , 2000, The Cochrane database of systematic reviews.

[53]  Robyn Norton,et al.  A comparison of albumin and saline for fluid resuscitation in the Intensive Care unit , 2005 .